Recruiting
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
NCT06865885
- Conditions
- Cardiometabolic Syndrome, Drug Interactions, Glucose Metabolism Disorders, +7 more
- Locations
-
- UC San Diego Altman Clinical and Translational Research Institute La Jolla, California, United States